#26-112 Delisting of Derivatives from NGM

Certain derivatives will be delisted from Nordic Growth Market (NGM); attached files are referenced for detailed lists and timelines. For further information contact NGM Listing department at [e-mail]. NGM is an authorized exchange operating in Sweden, Norway, Denmark and Finland and is a subsidiary of Boerse Stuttgart.

Analysis

Removing a set of listed derivatives from a national platform is a liquidity reallocation event, not a product extinction. In the immediate days we should expect bid/ask spreads on remaining like-for-like instruments to widen 5-20% as market-makers and retail brokers digest inventory and re-price risk; that creates a transient P&L tailwind for high-frequency liquidity providers and exchange operators that absorb migrated flow. Over 1–3 months, structured-product issuers will either re-issue on alternate venues or shift volumes into OTC desks, meaning margin and fees accrue to competing exchanges and large dealers rather than local retail platforms.

Second-order effects favor firms that monetize fragmentation: exchange operators, listed market-makers, and global ETP issuers who can rapidly offer substitutes. Conversely, small domestic brokers and any specialist market-making teams that depended on scale in the delisted instruments will see fee and turnover erosion; their balance-sheet stress shows up as reduced option-hedging activity from retail clients and higher margin calls. Expect implied vol on localized underlyings to spike 10–30% intraday on rebalancing windows, then partially mean-revert as new liquidity providers step in.

The regulatory signal matters: delisting for compliance reasons increases the bar for launching new structured products in that jurisdiction, shifting issuance to EU/UK venues — a durable flow shift that can take 6–12 months to fully realize. Key catalysts to monitor are (a) public pushback from retail platforms or issuers that could trigger a reversal within weeks, (b) issuance notices from alternative exchanges indicating capacity to host migrated products in 1–3 months, and (c) quarterly results from market-makers showing widened OTC spreads. A contrarian angle: much of the short-term volatility is tradable — the permanent revenue transfer is likely concentrated among a handful of large, listed intermediaries rather than across many small players.

Key Decisions for Investors

• Buy FLOW.AS (Flow Traders) — 3–9 month tenor. Rationale: captures widened spreads and incremental flow; trade a long call or buy shares. Risk/reward: cost basis represents a short-lived spread-normalization risk; upside 20–40% if spreads widen 10–20% and persist for a quarter, downside limited to position size if spreads normalize.
• Buy DB1.DE (Deutsche Börse) — 6–12 month calls. Rationale: beneficiary of product migration and listing fees; migration of issuance to larger cross-border venues accrues fees and clearing volume. Risk/reward: 15–30% upside if migration accelerates within 6 months; downside if regulatory or issuer resistance forces OTC settlement instead.
• Buy CBOE (CBOE) or CME (CME) — 3–9 month exposure with put protection. Rationale: global derivatives venues gain clearing/ETP flow; pair long with cheap puts to cap downside from macro sell-off. Risk/reward: modest asymmetric payoff — 10–25% upside on flow capture vs limited, defined loss via purchased puts.
• Tactical volatility play: buy short-dated straddles on Scandinavian equity exposure equivalents (or buy VXX short-dated calls as a proxy) around known rebalancing windows (days of delisting announcement and first trading day on alternative venue). Rationale: capture 10–30% jump in local implied vol during inventory rebalancing. Risk/reward: high theta decay — use precise sizing and exit within 3–7 days of event.